trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['enhertu', 'rectal', 'colorectal']
at #asco22 everyone is talking enhertu - but this was my highlight. if the cr holds, then we have just 'cured' a very small subset of colorectal cancer patients. durable crs should be celebrated. 
PhD in cancer biology | Biotech | Entrepreneur | Writer 
????